(TEAM) Atlassian - Overview
Sector: TechnologyIndustry: Software - Application | Exchange NASDAQ (USA) | Currency USD | Market Cap: 17.979m | Total Return -70.8% in 12m
Stock: Project Management, Collaboration, Development, Service Management, AI
Total Rating 23
Risk 33
Buy Signal -1.58
| Risk 5d forecast | |
|---|---|
| Volatility | 58.3% |
| Relative Tail Risk | -8.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -2.14 |
| Alpha | -91.07 |
| Character TTM | |
|---|---|
| Beta | 1.775 |
| Beta Downside | 2.448 |
| Drawdowns 3y | |
|---|---|
| Max DD | 79.84% |
| CAGR/Max DD | -0.35 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: TEAM Atlassian March 04, 2026
Atlassian Corporation (TEAM) provides collaboration software globally. Their product portfolio includes Jira for project management, Confluence for knowledge sharing, and Loom for asynchronous video communication. The company also offers Jira Service Management for IT/HR, and Rovo, an AI offering for search, chat, and agent capabilities.
Additional products include Bitbucket for source code management, Compass for developer portals, and Jira Product Discovery for product idea management. Jira Align provides enterprise agility, while Focus and Talent support leadership and workforce planning. Trello is an AI-powered productivity tool, and Guard offers security threat detection.
The company operates within the application software sector, which is characterized by subscription-based revenue models. Atlassians business model relies on recurring revenue from software licenses and cloud subscriptions.
Further research on ValueRay can provide deeper insights into Atlassians financial performance and market position.
Headlines to watch out for
- Cloud subscription growth drives recurring revenue
- New AI product Rovo expands enterprise offerings
- Competition from Microsoft and Google impacts market share
- Economic downturns reduce corporate software spending
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -189.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA -4.83 > 1.0 |
| NWC/Revenue: -5.92% < 20% (prev 13.29%; Δ -19.21% < -1%) |
| CFO/TA 0.21 > 3% & CFO 1.32b > Net Income -189.2m |
| Net Debt (232.7m) to EBITDA (11.4m): 20.35 < 3 |
| Current Ratio: 0.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (263.4m) vs 12m ago 0.87% < -2% |
| Gross Margin: 83.51% > 18% (prev 0.82%; Δ 8.27k% > 0.5%) |
| Asset Turnover: 99.25% > 50% (prev 88.04%; Δ 11.21% > 0%) |
| Interest Coverage Ratio: -2.56 > 6 (EBITDA TTM 11.4m / Interest Expense TTM 37.1m) |
Altman Z'' -4.11
| A: -0.06 (Total Current Assets 2.78b - Total Current Liabilities 3.12b) / Total Assets 6.16b |
| B: -0.78 (Retained Earnings -4.79b / Total Assets 6.16b) |
| C: -0.02 (EBIT TTM -94.9m / Avg Total Assets 5.80b) |
| D: -1.05 (Book Value of Equity -4.79b / Total Liabilities 4.57b) |
| Altman-Z'' Score: -4.11 = D |
Beneish M -2.78
| DSRI: 1.09 (Receivables 911.9m/695.7m, Revenue 5.76b/4.79b) |
| GMI: 0.98 (GM 83.51% / 81.82%) |
| AQI: 1.50 (AQ_t 0.51 / AQ_t-1 0.34) |
| SGI: 1.20 (Revenue 5.76b / 4.79b) |
| TATA: -0.25 (NI -189.2m - CFO 1.32b) / TA 6.16b) |
| Beneish M-Score: -2.78 (Cap -4..+1) = A |
What is the price of TEAM shares?
As of March 28, 2026, the stock is trading at USD 65.12 with a total of 5,714,538 shares traded.
Over the past week, the price has changed by -11.68%, over one month by -13.32%, over three months by -60.29% and over the past year by -70.75%.
Over the past week, the price has changed by -11.68%, over one month by -13.32%, over three months by -60.29% and over the past year by -70.75%.
Is TEAM a buy, sell or hold?
Atlassian has received a consensus analysts rating of 4.36.
Therefore, it is recommended to buy TEAM.
- StrongBuy: 19
- Buy: 7
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TEAM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 168.9 | 159.4% |
| Analysts Target Price | 168.9 | 159.4% |
TEAM Fundamental Data Overview March 26, 2026
P/E Forward = 13.245
P/S = 3.1215
P/B = 12.2236
P/EG = 0.6618
Revenue TTM = 5.76b USD
EBIT TTM = -94.9m USD
EBITDA TTM = 11.4m USD
Long Term Debt = 988.6m USD (from longTermDebt, last quarter)
Short Term Debt = 50.7m USD (from shortTermDebt, last quarter)
Debt = 1.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 232.7m USD (from netDebt column, last quarter)
Enterprise Value = 17.80b USD (17.98b + Debt 1.39b - CCE 1.57b)
Interest Coverage Ratio = -2.56 (Ebit TTM -94.9m / Interest Expense TTM 37.1m)
EV/FCF = 14.04x (Enterprise Value 17.80b / FCF TTM 1.27b)
FCF Yield = 7.12% (FCF TTM 1.27b / Enterprise Value 17.80b)
FCF Margin = 22.02% (FCF TTM 1.27b / Revenue TTM 5.76b)
Net Margin = -3.29% (Net Income TTM -189.2m / Revenue TTM 5.76b)
Gross Margin = 83.51% ((Revenue TTM 5.76b - Cost of Revenue TTM 949.7m) / Revenue TTM)
Gross Margin QoQ = 85.02% (prev 82.00%)
Tobins Q-Ratio = 2.89 (Enterprise Value 17.80b / Total Assets 6.16b)
Interest Expense / Debt = 0.90% (Interest Expense 12.5m / Debt 1.39b)
Taxrate = 21.0% (US default 21%)
NOPAT = -75.0m (EBIT -94.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.89 (Total Current Assets 2.78b / Total Current Liabilities 3.12b)
Debt / Equity = 0.87 (Debt 1.39b / totalStockholderEquity, last quarter 1.59b)
Debt / EBITDA = 20.35 (Net Debt 232.7m / EBITDA 11.4m)
Debt / FCF = 0.18 (Net Debt 232.7m / FCF TTM 1.27b)
Total Stockholder Equity = 1.42b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.26% (Net Income -189.2m / Total Assets 6.16b)
RoE = -13.32% (Net Income TTM -189.2m / Total Stockholder Equity 1.42b)
RoCE = -3.94% (EBIT -94.9m / Capital Employed (Equity 1.42b + L.T.Debt 988.6m))
RoIC = -3.11% (negative operating profit) (NOPAT -75.0m / Invested Capital 2.41b)
WACC = 11.40% (E(17.98b)/V(19.37b) * Re(12.23%) + D(1.39b)/V(19.37b) * Rd(0.90%) * (1-Tc(0.21)))
Discount Rate = 12.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.93%
[DCF] Terminal Value 69.50% ; FCFF base≈1.31b ; Y1≈1.51b ; Y5≈2.09b
[DCF] Fair Price = 125.5 (EV 21.52b - Net Debt 232.7m = Equity 21.29b / Shares 169.6m; r=11.40% [WACC]; 5y FCF grow 16.95% → 3.0% )
EPS Correlation: -1.61 | EPS CAGR: -23.10% | SUE: 0.06 | # QB: 0
Revenue Correlation: 99.33 | Revenue CAGR: 22.53% | SUE: 1.46 | # QB: 2
EPS current Year (2026-06-30): EPS=4.76 | Chg7d=+0.003 | Chg30d=-0.002 | Revisions Net=+0 | Growth EPS=+29.4% | Growth Revenue=+22.2%
EPS next Year (2027-06-30): EPS=5.53 | Chg7d=+0.007 | Chg30d=+0.017 | Revisions Net=+1 | Growth EPS=+16.2% | Growth Revenue=+17.7%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Current Year)
P/S = 3.1215
P/B = 12.2236
P/EG = 0.6618
Revenue TTM = 5.76b USD
EBIT TTM = -94.9m USD
EBITDA TTM = 11.4m USD
Long Term Debt = 988.6m USD (from longTermDebt, last quarter)
Short Term Debt = 50.7m USD (from shortTermDebt, last quarter)
Debt = 1.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 232.7m USD (from netDebt column, last quarter)
Enterprise Value = 17.80b USD (17.98b + Debt 1.39b - CCE 1.57b)
Interest Coverage Ratio = -2.56 (Ebit TTM -94.9m / Interest Expense TTM 37.1m)
EV/FCF = 14.04x (Enterprise Value 17.80b / FCF TTM 1.27b)
FCF Yield = 7.12% (FCF TTM 1.27b / Enterprise Value 17.80b)
FCF Margin = 22.02% (FCF TTM 1.27b / Revenue TTM 5.76b)
Net Margin = -3.29% (Net Income TTM -189.2m / Revenue TTM 5.76b)
Gross Margin = 83.51% ((Revenue TTM 5.76b - Cost of Revenue TTM 949.7m) / Revenue TTM)
Gross Margin QoQ = 85.02% (prev 82.00%)
Tobins Q-Ratio = 2.89 (Enterprise Value 17.80b / Total Assets 6.16b)
Interest Expense / Debt = 0.90% (Interest Expense 12.5m / Debt 1.39b)
Taxrate = 21.0% (US default 21%)
NOPAT = -75.0m (EBIT -94.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.89 (Total Current Assets 2.78b / Total Current Liabilities 3.12b)
Debt / Equity = 0.87 (Debt 1.39b / totalStockholderEquity, last quarter 1.59b)
Debt / EBITDA = 20.35 (Net Debt 232.7m / EBITDA 11.4m)
Debt / FCF = 0.18 (Net Debt 232.7m / FCF TTM 1.27b)
Total Stockholder Equity = 1.42b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.26% (Net Income -189.2m / Total Assets 6.16b)
RoE = -13.32% (Net Income TTM -189.2m / Total Stockholder Equity 1.42b)
RoCE = -3.94% (EBIT -94.9m / Capital Employed (Equity 1.42b + L.T.Debt 988.6m))
RoIC = -3.11% (negative operating profit) (NOPAT -75.0m / Invested Capital 2.41b)
WACC = 11.40% (E(17.98b)/V(19.37b) * Re(12.23%) + D(1.39b)/V(19.37b) * Rd(0.90%) * (1-Tc(0.21)))
Discount Rate = 12.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.93%
[DCF] Terminal Value 69.50% ; FCFF base≈1.31b ; Y1≈1.51b ; Y5≈2.09b
[DCF] Fair Price = 125.5 (EV 21.52b - Net Debt 232.7m = Equity 21.29b / Shares 169.6m; r=11.40% [WACC]; 5y FCF grow 16.95% → 3.0% )
EPS Correlation: -1.61 | EPS CAGR: -23.10% | SUE: 0.06 | # QB: 0
Revenue Correlation: 99.33 | Revenue CAGR: 22.53% | SUE: 1.46 | # QB: 2
EPS current Year (2026-06-30): EPS=4.76 | Chg7d=+0.003 | Chg30d=-0.002 | Revisions Net=+0 | Growth EPS=+29.4% | Growth Revenue=+22.2%
EPS next Year (2027-06-30): EPS=5.53 | Chg7d=+0.007 | Chg30d=+0.017 | Revisions Net=+1 | Growth EPS=+16.2% | Growth Revenue=+17.7%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Current Year)